Curated News
By: NewsRamp Editorial Staff
June 08, 2026
Gene Therapy and Cancer Care Startups Win Superpowers for Good Pitch
TLDR
- Rejuvenate Bio won Judges' Choice for gene therapies targeting age-related diseases, offering a competitive edge in longevity.
- The event featured four companies pitching via Regulation Crowdfunding, with judges and audience selecting winners based on impact and traction.
- Eisana Health's mobile cooling system reduces chemotherapy side effects, improving cancer patients' quality of life.
- Audience voting was remarkably close, highlighting strong public engagement with high-impact health innovations.
Impact - Why it Matters
This news matters because it showcases early-stage companies that are addressing critical health challenges: Rejuvenate Bio's gene therapies could revolutionize treatment for age-related diseases in both animals and humans, while Eisana Health's cooling system offers a non-invasive solution to a debilitating side effect of chemotherapy. For investors and the public, these innovations represent opportunities to support impactful ventures with potential for significant financial and social returns. The live pitch format also democratizes access to startup investing, allowing ordinary people to discover and fund groundbreaking technologies.
Summary
The Super Crowd, Inc., a public benefit corporation, recently hosted its quarterly Superpowers for Good Live Pitch, broadcast live on the e360tv Network. The event featured four innovative companies raising capital through Regulation Crowdfunding: Eisana Health, Emission Free Generators, Rejuvenate Bio, and SenoGuard. Each company pitched live, answered questions from a panel of expert judges, and engaged with the viewing audience. The judges selected Rejuvenate Bio as the Judges’ Choice Award winner, while the live audience chose Eisana Health for the SuperCrowd Award.
Rejuvenate Bio, led by CEO Daniel Oliver, is developing one-time gene therapies designed to address chronic, age-related diseases. Starting with companion animals, the company aims to build toward broader human longevity. Oliver expressed gratitude for the award, noting that the pitch provided a powerful opportunity to share their vision for extending healthspan through gene therapy. Eisana Health, led by CEO Carole Spangler Vaughn, is developing a mobile cooling system to help reduce chemotherapy-induced peripheral neuropathy, a painful side effect of cancer treatment. Vaughn emphasized the personal and urgent mission to help cancer patients preserve quality of life during and after treatment.
The judging panel included Paul Lovejoy, Teddy Lyons, and Sherwood “Woodie” Neiss. Devin Thorpe, CEO of The Super Crowd, Inc., noted the difficulty in selecting winners, praising both Rejuvenate Bio’s ambitious science and Eisana Health’s patient-centered mission. The event, broadcast on e360tv Network via Roku and Amazon Fire TV, highlights companies with potential for financial return and social impact. For more information, visit TheSuperCrowd.com.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, Gene Therapy and Cancer Care Startups Win Superpowers for Good Pitch
